Overview

Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

Status:
Completed
Trial end date:
2010-07-25
Target enrollment:
Participant gender:
Summary
Treatment, Randomised, Double Blind, Parallel Assignment, Safety/efficacy Study
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone
Xhance